EMILY ESSERT, D.O.

Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use

Transitional care management services for problem of high complexity

Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment

Established patient office or other outpatient visit, 40-54 minutes

Established patient office or other outpatient visit, 30-39 minutes

Advance care planning, first 30 minutes

Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit

Established patient office or other outpatient visit, 20-29 minutes

Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and

Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report

Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or

Influenza vaccine split virus, preservative free

Injection, denosumab, 1 mg

Administration of influenza virus vaccine

Injection of drug or substance under skin or into muscle

Administration of pneumococcal vaccine

Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg

Insertion of needle into vein for collection of blood sample

Automated urinalysis test